{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:14Z","timestamp":1791357494386,"version":"4.3.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2016CQ18"],"award-info":[{"award-number":["ZR2016CQ18"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2015M580592"],"award-info":[{"award-number":["2015M580592"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2016T90637"],"award-info":[{"award-number":["2016T90637"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.intimp.2019.01.033","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T11:58:20Z","timestamp":1548676700000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Phenobarbital inhibits osteoclast differentiation and function through NF-\u03baB and MAPKs signaling pathway"],"prefix":"10.1016","volume":"69","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2019.01.033_bb0005","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat. Rev. Genet."},{"issue":"6274","key":"10.1016\/j.intimp.2019.01.033_bb0010","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/345442a0","article-title":"The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene","volume":"345","author":"Yoshida","year":"1990","journal-title":"Nature"},{"issue":"6937","key":"10.1016\/j.intimp.2019.01.033_bb0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2019.01.033_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","article-title":"The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption","volume":"15","author":"Hofbauer","year":"2000","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.intimp.2019.01.033_bb0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.intimp.2019.01.033_bb0030","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"issue":"9","key":"10.1016\/j.intimp.2019.01.033_bb0035","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","article-title":"Autoamplification of NFATc1 expression determines its essential role in bone homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2019.01.033_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/path.1711360104","article-title":"Calcitonin alters behaviour of isolated osteoclasts","volume":"136","author":"Chambers","year":"1982","journal-title":"J. Pathol."},{"issue":"Pt 3","key":"10.1016\/j.intimp.2019.01.033_bb0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1242\/jcs.113.3.377","article-title":"The cell biology of osteoclast function","volume":"113","author":"Vaananen","year":"2000","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.intimp.2019.01.033_bb0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1359\/JBMR.051204","article-title":"Pharmacological sequestration of intracellular cholesterol in late endosomes disrupts ruffled border formation in osteoclasts","volume":"21","author":"Zhao","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.intimp.2019.01.033_bb0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-5793(95)00153-Z","article-title":"Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption","volume":"361","author":"Nakamura","year":"1995","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.intimp.2019.01.033_bb0060","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1210\/endo.137.11.8895334","article-title":"Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts","volume":"137","author":"Suzuki","year":"1996","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.intimp.2019.01.033_bb0065","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1212\/WNL.51.5.1243","article-title":"Etiology as a risk factor for medically refractory epilepsy: a case for early surgical intervention","volume":"51","author":"Engel","year":"1998","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.intimp.2019.01.033_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17081242","article-title":"The impact of anti-epileptic drugs on growth and bone metabolism","volume":"17","author":"Fan","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2019.01.033_bb0075","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1053\/beog.2001.0234","article-title":"Drugs in pregnancy. Anticonvulsants and drugs for neurological disease","volume":"15","author":"Lowe","year":"2001","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"8","key":"10.1016\/j.intimp.2019.01.033_bb0080","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/ajmg.a.35438","article-title":"Antiepileptic drugs and pregnancy outcomes","volume":"158A","author":"Wlodarczyk","year":"2012","journal-title":"Am. J. Med. Genet. Part A"},{"issue":"6","key":"10.1016\/j.intimp.2019.01.033_bb0085","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.seizure.2012.04.014","article-title":"Trends in antiepileptic drug utilisation in UK primary care 1993-2008: cohort study using the general practice research database","volume":"21","author":"Nicholas","year":"2012","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.intimp.2019.01.033_bb0090","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI106868","article-title":"Phenobarbital-induced alterations in vitamin D metabolism","volume":"51","author":"Hahn","year":"1972","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2019.01.033_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archneurol.2010.341","article-title":"H.J. Prior, J. McChesney, W.D. Leslie, association of antiepileptic drugs with nontraumatic fractures: a population-based analysis","volume":"68","author":"Jette","year":"2011","journal-title":"Arch. Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2019.01.033_bb0100","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.yebeh.2003.11.026","article-title":"Pathophysiology of bone loss in patients receiving anticonvulsant therapy","volume":"5","author":"Fitzpatrick","year":"2004","journal-title":"Epilepsy Behav."},{"issue":"8","key":"10.1016\/j.intimp.2019.01.033_bb0105","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1359\/jbmr.090302","article-title":"Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling","volume":"24","author":"Koide","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.intimp.2019.01.033_bb0110","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/oxfordjournals.jbchem.a022505","article-title":"A general method for rapid purification of soluble versions of glycosylphosphatidylinositol-anchored proteins expressed in insect cells: an application for human tissue-nonspecific alkaline phosphatase","volume":"126","author":"Oda","year":"1999","journal-title":"J. Biochem."},{"issue":"3","key":"10.1016\/j.intimp.2019.01.033_bb0115","first-page":"327","article-title":"Histological examination on osteoblastic activities in the alveolar bone of transgenic mice with induced ablation of osteocytes","volume":"28","author":"Li","year":"2013","journal-title":"Histol. Histopathol."},{"issue":"1","key":"10.1016\/j.intimp.2019.01.033_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jcb.22800","article-title":"Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-kappaB and ERK","volume":"112","author":"Ang","year":"2011","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.intimp.2019.01.033_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023199","article-title":"P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption","volume":"6","author":"Tao","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.intimp.2019.01.033_bb0130","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1359\/jbmr.080211","article-title":"JNK\/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts","volume":"23","author":"Ikeda","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.intimp.2019.01.033_bb0135","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1097-2765(00)80232-4","article-title":"TRANCE, a TNF family member, activates Akt\/PKB through a signaling complex involving TRAF6 and c-Src","volume":"4","author":"Wong","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2019.01.033_bb0140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bone.2016.03.016","article-title":"Estrogen receptors alpha and beta in bone","volume":"87","author":"Khalid","year":"2016","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.intimp.2019.01.033_bb0145","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1248\/bpb.b17-00482","article-title":"Effects of the antiepileptic drugs phenytoin, gabapentin, and Levetiracetam on bone strength, bone mass, and bone turnover in rats","volume":"40","author":"Kanda","year":"2017","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.intimp.2019.01.033_bb0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1442-200X.2002.01561.x","article-title":"Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy","volume":"44","author":"Tsukahara","year":"2002","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.intimp.2019.01.033_bb0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fphar.2016.00349","article-title":"Exposure to excess phenobarbital negatively influences the osteogenesis of Chick embryos","volume":"7","author":"Yan","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"5727","key":"10.1016\/j.intimp.2019.01.033_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/bmj.4.5727.69","article-title":"Osteomalacia with long-term anticonvulsant therapy in epilepsy","volume":"4","author":"Dent","year":"1970","journal-title":"Br. Med. J."},{"issue":"2","key":"10.1016\/j.intimp.2019.01.033_bb0165","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1172\/JCI109142","article-title":"Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro","volume":"62","author":"Hahn","year":"1978","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2019.01.033_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.seizure.2012.10.002","article-title":"Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: cohort study using the general practice research database","volume":"22","author":"Nicholas","year":"2013","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.intimp.2019.01.033_bb0175","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1531-8249(200003)47:3<385::AID-ANA18>3.0.CO;2-W","article-title":"Increased bone turnover in epileptic patients treated with carbamazepine","volume":"47","author":"Verrotti","year":"2000","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2019.01.033_bb0180","first-page":"37","article-title":"Long-term anticonvulsant therapy leads to low bone mineral density--evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells","volume":"108","author":"Feldkamp","year":"2000","journal-title":"Exp. Clin. Endocr. Diab."},{"issue":"5","key":"10.1016\/j.intimp.2019.01.033_bb0185","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archneur.59.5.781","article-title":"Antiepileptic drug-induced bone loss in young male patients who have seizures","volume":"59","author":"Andress","year":"2002","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2019.01.033_bb0190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amjopharm.2010.02.003","article-title":"A review of the effect of anticonvulsant medications on bone mineral density and fracture risk","volume":"8","author":"Lee","year":"2010","journal-title":"Am. J. Geriatr. Pharmacother."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691831021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691831021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T01:27:31Z","timestamp":1662859651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691831021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":38,"alternative-id":["S156757691831021X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.01.033","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenobarbital inhibits osteoclast differentiation and function through NF-\u03baB and MAPKs signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}